RCT Abstract - Airway smooth muscle mass to predict response to ICS in COPD patients receiving triple therapy (HISTORIC study): a randomized, placebo-controlled, double-blind, investigator-initiated trial
D. Stolz (Freiburg, Germany), E. Papakonstantinou (Basel, Switzerland), M. Pascarella (Basel, Switzerland), K. Jahn (Basel, Switzerland), A. Siebeneichler (Basel, Switzerland), A. Darie (Basel, Switzerland), M. Herrmann (Basel, Switzerland), W. Strobel (Basel, Switzerland), A. Salina (Basel, Switzerland), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland)
Source: International Congress 2022 – COPD treatment: new mechanisms and novel insights
Session: COPD treatment: new mechanisms and novel insights
Session type: Oral Presentation
Number: 9001
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Stolz (Freiburg, Germany), E. Papakonstantinou (Basel, Switzerland), M. Pascarella (Basel, Switzerland), K. Jahn (Basel, Switzerland), A. Siebeneichler (Basel, Switzerland), A. Darie (Basel, Switzerland), M. Herrmann (Basel, Switzerland), W. Strobel (Basel, Switzerland), A. Salina (Basel, Switzerland), L. Grize (Basel, Switzerland), M. Tamm (Basel, Switzerland). RCT Abstract - Airway smooth muscle mass to predict response to ICS in COPD patients receiving triple therapy (HISTORIC study): a randomized, placebo-controlled, double-blind, investigator-initiated trial. 9001
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|